Medpace (MEDP) Competitors

Medpace (NASDAQ:MEDP) and IQVIA (NYSE:IQV) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership, community ranking and valuation.

Do analysts recommend MEDP or IQV?

Medpace currently has a consensus price target of $349.30, indicating a potential upside of 14.90%. IQVIA has a consensus price target of $226.32, indicating a potential upside of 42.45%. Given IQVIA's stronger consensus rating and higher possible upside, analysts plainly believe IQVIA is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23
IQVIA	0 Sell rating(s)	7 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.75

Is MEDP or IQV more profitable?

Medpace has a net margin of 19.17% compared to IQVIA's net margin of 8.91%. Medpace's return on equity of 51.48% beat IQVIA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	19.17%	51.48%	20.47%
IQVIA	8.91%	28.81%	7.02%

Which has more volatility and risk, MEDP or IQV?

Medpace has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, IQVIA has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500.

Does the MarketBeat Community believe in MEDP or IQV?

IQVIA received 333 more outperform votes than Medpace when rated by MarketBeat users. Likewise, 67.99% of users gave IQVIA an outperform vote while only 62.81% of users gave Medpace an outperform vote.

Company	Underperform	Outperform
Medpace	Outperform Votes 353 62.81%	Underperform Votes 209 37.19%
IQVIA	Outperform Votes 686 67.99%	Underperform Votes 323 32.01%

Do insiders and institutionals hold more shares of MEDP or IQV?

78.0% of Medpace shares are owned by institutional investors. Comparatively, 89.6% of IQVIA shares are owned by institutional investors. 20.3% of Medpace shares are owned by insiders. Comparatively, 1.6% of IQVIA shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Which has stronger earnings & valuation, MEDP or IQV?

IQVIA has higher revenue and earnings than Medpace. IQVIA is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.16B	4.05	$404.39M	$13.10	23.21
IQVIA	$15.50B	1.77	$1.37B	$7.34	21.65

Does the media refer more to MEDP or IQV?

In the previous week, IQVIA had 9 more articles in the media than Medpace. MarketBeat recorded 15 mentions for IQVIA and 6 mentions for Medpace. Medpace's average media sentiment score of 1.20 beat IQVIA's score of 1.00 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IQVIA	11 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IQVIA beats Medpace on 10 of the 19 factors compared between the two stocks.